Trade Summary

4 months ago, Schall Thomas J., serving as Dir at Immuneering Corp (IMRX), purchased 21,645 shares at $4.67 per share, for a total transaction value of $101,041.00. Following this transaction, Schall Thomas J. now holds 74,530 shares of IMRX.

This purchase represents a 41.00% increase in Schall Thomas J.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, January 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, January 20, 2026 at 9:17 AM ET, 5 days after the trade was made.

Immuneering Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.